ArticleOncology reports2017

SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model.

Feng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.